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As first observed by Wittenberg (Kesti, T., Flick, K.,
Keranen, S., Syvaoja, J. E., and Wittenburg, C. (1999)
Mol. Cell 3, 679–685), we find that deletion mutants lack-
ing the entire N-terminal DNA polymerase domain of
yeast pol e are viable. However, we now show that point
mutations in DNA polymerase catalytic residues of pol e
are lethal. Taken together, the phenotypes of the dele-
tion and the point mutants suggest that the polymerase
of pol e may normally participate in DNA replication but
that another polymerase can substitute in its complete
absence. Substitution is inefficient because the deletion
mutants have serious defects in DNA replication. This
observation raises the question of what is the essential
function of the C-terminal half of pol e. We show that the
ability of the C-terminal half of the polymerase to sup-
port growth is disrupted by mutations in the cysteine-
rich region, which disrupts both dimerization of the
POL2 gene product and interaction with the essential
DPB2 subunit, suggesting that this region plays an im-
portant architectural role at the replication fork even in
the absence of the polymerase function. Finally, the S
phase checkpoint, with respect to both induction of
RNR3 transcription and cell cycle arrest, is intact in
cells where replication is supported only by the C-ter-
minal half of pol e, but it is disrupted in mutants affect-
ing the cysteine-rich region, suggesting that this domain
directly affects the checkpoint rather than acting
through the N-terminal polymerase active site.
In Saccharomyces cerevisiae, three DNA polymerases partic-
ipate in chromosomal DNA replication, pol1 a, pol d, and pol e.
pol a is primarily involved in the initiation of DNA replication
and priming of Okazaki fragments (2), whereas pol d and pol e
are required for completion of synthesis of both the leading and
lagging strands. The precise reactions performed by pol d and
pol e on leading and lagging strands, however, have not yet
been delineated. In an interesting contrast to yeast chromo-
somes, simian virus 40 DNA replication does not require pol e.
Instead, pol a and pol d are sufficient for viral DNA replication
(3). Thus, there appears to be some plasticity in the eukaryotic
replication fork.
Pol e is a multi-subunit complex consisting of Pol2p, Dpb2p,
Dpb3p, and Dpb4p (4). The Pol2p is the catalytic subunit, and
it is encoded by the POL2 gene (5). The Pol2p is a class B
polymerase, characterized by a series of conserved domains,
called domains I–VI, containing the exonuclease subdomains
and the DNA polymerase active site residues in the N-terminal
half of the protein (Fig. 1A) (6, 7). Mutations M643I and P710S
(the pol2-9 and pol2-18 alleles, respectively) within the polym-
erase domain in POL2 result in temperature sensitivity (8).
The remaining half of POL2 consists of a long region that is
conserved in pol e from all organisms but is not found in any
other class B polymerase. An interesting feature of the extreme
C terminus is a cysteine-rich stretch of amino acids containing
two putative zinc fingers, ZF1 and ZF2 (Figs. 1A and 2) (9).
Although all of the essential polymerases have a cysteine-rich
domain in a similar location, the specific amino acids are better
conserved among pol e proteins from different organisms than
between pol a, pol d, and pol e from the same species (10). The
C terminus of POL2 has been shown to have a dual role (11).
Unlike the N-terminal pol2-9 and pol2-18 mutants, which have
defects only in DNA replication, pol2-11 and pol2-12, which are
non-sense mutations about 30 amino acids from the termina-
tion codon, have defects in both DNA replication and in the
cellular response to DNA damage during S phase, known as the
S/M checkpoint (11–13). In investigating the molecular basis
for these defects, we showed that the C-terminal half of POL2
is important in the assembly of the pol e holoenzyme, a finding
supported by suppressor studies, synthetic lethal tests, and
purification of various pol e subassemblies from yeast (4, 14,
15). We discovered that pol e can dimerize and that a 10-amino
acid deletion between ZF1 and ZF2 that results in a replication
and checkpoint defect both abolishes self-interaction and re-
duces the ability of Pol2p to interact with Dpb2p (9). In addi-
tion to mediating essential protein/protein interactions, the
C-terminal 100-kDa portion of Pol2p might also contribute to
the binding of single-stranded or other non-B form DNA (16).
One unanswered question is whether the C-terminal portion of
the protein acts independently or whether it modifies some
function of the N-terminal polymerase domain.
Are the replication and checkpoint functions of POL2 sepa-
rable? The polymerase activity and the checkpoint functions
are at least in some sense independent, because the N-terminal
pol2-9 and pol2-18 mutants appear to be defective in replica-
tion but, unlike pol2-11 and pol2-12, proficient in the S/M
checkpoint. However, recently, Wittenberg and colleagues (1)
have made the somewhat counterintuitive discovery that cells
tolerate deletion of the entire polymerase domain of POL2,
suggesting that the polymerase activity is not the essential
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replication function of the POL2 gene product. It now appears
that the only nonredundant essential function of pol e lies in its
C terminus, which has no known catalytic activity. This finding
is in keeping with the nonviability of C-terminal deletions (9,
11) and helps explain the fact that the pol2-18 mutant can be
complemented partially by overproduction of a large C-termi-
nal fragment entirely lacking the polymerase domain (11) but
not by C-terminal mutants (9). To further define the relative
contributions of the polymerase domain and the C-terminal
half of the protein to events at the replication fork and in the
checkpoint, we have made an N-terminal deletion mutant that,
in accord with the results of Wittenberg (1), is viable and has an
intact S/M checkpoint. We have extended that work by pinpoint-
ing, via site-directed mutagenesis, regions essential for function.
EXPERIMENTAL PROCEDURES
Materials—Plasmid PTZ18 was from Bio-Rad. Plasmid pLitmus39
and M13 phage M13KO7 were from New England Biolabs, as were the
FIG. 1. Characterization of deletion and point mutations affecting the N-terminal half of pol e. A, site-specific deletion of the
polymerase domain of POL2 and preparation of the pol2 catalytic site mutant. Amino acids 176–1135 containing the polymerase domain were
deleted, and the catalytic site mutant was prepared as described under “Experimental Procedures.” The mutant pol2 genes were subcloned into
the pRS314 vector and introduced into strain A1128 pol2-3::LEU2(YEpPOL2). The transformants were replica-plated to agar plates lacking
tryptophan and containing 5-fluoroorotic acid at 24 and 37 °C for 4 days, as described previously (9). The symbols 111, 11, and 2 refer to normal
growth, slow growth, and no growth, respectively, on agar plates. B, amino acid alignments showing the conservation of catalytic residues in
polymerases. Bacteriophage RB69 and T4, herpes simplex virus (HSV1), E. coli pol II (ePolB), S. cerevisiae pol a (yPola), S. cerevisiae pol e (yPole),
and S. cerevisiae pol d (yPold) polymerases are shown (25). The conserved aspartates are boxed. C, flow cytometric analysis of pol2-M. Mid-log phase
pol2-M cells were blocked in G1 with 8 mg/ml a-factor and grown for 4 h at 24 °C. Additional a-factor was added twice at 2-h intervals. The cells
were washed with YPD to remove the a-factor, and the culture was transferred to 37 °C. The cells were collected at indicated time intervals, fixed
with ethanol, and treated with 20 mg/ml RNase. The DNA was stained with propidium iodide, and at least 10,000 cells were examined by flow
cytometry. D, PFGE analysis of chromosomes in pol2-M. Cells were grown at 30 °C and transferred to 37 °C for 4 h. PFGE was carried out as
described previously (29). Lane 1, POL2; lane 2, pol2-M; lane 3, pol2-F; lane M, PFGE markers. E, nuclear staining. The asynchronous POL2 and
pol2-M cells were fixed with ethanol, and the nucleoid was observed using DAPI.
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restriction enzymes, T4 DNA ligase, and Klenow fragment. CJ236
Escherichia coli strain and the mutagenesis kit were obtained from
Bio-Rad. DH5a bacterial strain used for routine subcloning was from
Life Technologies Inc. All oligonucleotides were synthesized by the
oligonucleotide facility at the California Institute of Technology. Plas-
mid purification was done from Qiagen miniprep kits. ECL Western
blotting reagents were obtained from Amersham Pharmacia Biotech.
The reagents for Western blotting using the alkaline phosphatase
method were from Roche Molecular Biochemicals. The polyclonal anti-
body for the pol e holoenzyme complex was provided by Dr. Akio Sugino
from Osaka University, Japan.
Mutagenesis and Subcloning—The deletion of amino acids 176–1135
(polymerase domain) in pol e was as follows. The pK series of plasmids
containing the POL2 or mutant pol2 genes (9) were digested with BglII.
The resulting linearized plasmids were self-ligated and transformed
into DH5a cells, which resulted in an in-frame deletion of the BglII
fragment (amino acids 176–1135) in each plasmid as confirmed by DNA
sequencing. The resulting series of plasmids is designated the pL series.
To construct the catalytic site mutations, the N terminus of POL2
from pRPOL2 (9) was subcloned into the pTZ18 vector at the SacI site.
The uracil-phagemid was prepared and mutagenesis was performed as
described (9). After mutations were confirmed by DNA sequencing, the
POL2 gene was reconstituted by subcloning the BglII fragment into the
pL1 of the pL series plasmids. The mutagenic oligonucleotide for the
D875A,D877A double mutation was 59-CA CCA AAT ACC AGC AGT A-
GC TAA TTC TAA TG-39.
For mutagenesis of ZF1 and ZF2, pLitPOL2, which contains the C
terminus of POL2 (9), was used to prepare the uracil-phagemid tem-
plate, and mutagenesis was performed according to the instructions of
the supplier (Bio-Rad). After mutations were confirmed by DNA se-
quencing, the POL2 gene was reconstituted by subcloning into the
pRPOL2 vector containing the N terminus of POL2 as described previ-
ously for the pK series (9) The oligonucleotides used for the mutagenesis
were as follows: C2108A,C2111A, 59-C AGA AAT GAA AAA GGC GTA-
TTC GGC TAA AAA ATC CG-39; C2130A,C2133A, 59-GGC TTT GTG-
GGC TCT GAC GGC TGA AAA AAT AG-39; C2164A,C2167A, 59-CAC-
TTT ATG GGC TCT GGA GGC TCT CAA ATC-39; and C2179A,
C2181A, 59-CGC GCC GGC GGC TGG GGC GTG GGC ACT C-39.
RESULTS
Deletion of Amino Acids 176–1135, the Catalytic Domain of
pol e—To further define the replication and S/M checkpoint
function of the C-terminal half of pol e, we deleted the catalytic
polymerase domain of the Pol2p. Maki and colleagues (16)
recently showed that Pol2p amino acids 191–1270 are suffi-
cient for the polymerase activity of pol e. We removed most of
this region, amino acids 176–1135, including conserved do-
mains I–VI (see Fig. 1A), to produce mutant pol2-M. pol2-M
was introduced by plasmid shuffling into a strain containing a
complete deletion of the resident POL2 gene, as described
previously (9), and the ability of pol2-M to support growth was
assessed (Fig. 1, Table I). The pol2-M mutant was viable at
both 23 and 37 °C, although the doubling time was increased
even at 23 °C, and cells were mostly “dumbbells” and extremely
enlarged at 37 °C, suggesting a defect in cell cycle progression
(Fig. 1E). Similar observations have been reported by Witten-
berg (1).
To scrutinize the defect in the cell cycle, pol2-M cells were
grown at 23 °C to log phase, blocked in G1 with a factor, and
then released from pheromone block at 37 °C. Samples were
collected at various intervals, and their DNA content was an-
alyzed by flow cytometry (Fig. 1C). pol2-M cells proceeded
through the cell cycle, but more slowly than wild type, as seen
best in the 4-h sample. A comparison of the asynchronous
wild-type and pol2-M cells grown at 23 °C, before the addition
of pheromone, revealed that the wild-type population is evenly
divided between 1C and 2C DNA content, but the pol2-M cells
are mostly in S phase, with a DNA content between 1C and 2C,
also indicating a slowing of S phase. The state of the DNA in
the asynchronous culture was probed by pulsed field gels. As
shown in Fig. 1D, the bulk of the pol2-M DNA enters the gel,
the same as for wild type. By contrast, DNA in a pol2-F mutant,
which contains a temperature-sensitive mutation in the C-
terminal region, does not enter the gel, as expected if most of
the cells contain chromosomes with activated but stalled rep-
licons (17). Thus, Fig. 1, C and D, shows that DNA replication
is delayed but ultimately completed in pol2-M cells. Micro-
scopic examination of the log phase pol2-M cells shows that
they are greatly enlarged compared with wild type, and DAPI
staining shows many large-budded cells with a nucleus that is
undivided, again suggesting an S phase delay (Fig. 1E). The
cell cycle delay observed in these experiments suggests that
there may be some damage occurring and that the S/M check-
point is functioning normally in pol2-M strains, which is inves-
tigated further below.
Effect of Point Mutations in the Polymerase Catalytic Site—
The defects in pol2-M suggest that the polymerase domain of
pol e does indeed normally participate in DNA replication but
that in the absence of the polymerase domain another polym-
erase can carry out its function, albeit less efficiently. Support-
ing this idea, when the highly conserved, putative catalytic
residues of the polymerase active site (region I, Fig. 1B), Asp-
875 and Asp-877, were changed to alanines, the double point
mutation was lethal (Fig. 1A, mutant labeled pol2-X). We pro-
pose that when the polymerase domain is present but catalyt-
ically dead, it blocks any other polymerase from compensating.
A similar argument might explain why pol2-18, a point muta-
tion mapping to region II, part of the nucleoside triphosphate
substrate binding site in POL2, is temperature-sensitive for
growth (8).
Effect of Mutations in the Cysteine-rich Domain of pol2-M—
The small deletion mutations that we described previously, A
through L, spanning amino acids 2103 to the end, as well as the
pol2-11 mutation (Fig. 2), were introduced into the pol2-M gene
(9). In addition, we created new point mutations in the cys-
TABLE I
Effect of small C-terminal deletions and Cys-to-Ala mutations in ZF1
and ZF2 on the growth of the pol2-M polymerase domain deletion
mutant
Mutants Mutations (aa) Growth Growth
23 °C 37 °C
POL2 111 111
pol2-M D176–1135 11 11
Small deletions
pol2-M/A–I; K deletions A–I; Ka 2 2
pol2-M/J 11 11
pol2-M/L 11 11
Zinc finger 1
pol2-M/N C1 1 C2* 2 2
pol2-M/O C3 1 C4 2 2
pol2-M/P C1–C4 2 2
Zinc finger 2
pol2-M/Q C5 1 C6 11 2
pol2-M/R C7 1 C8 11 11
pol2-M/S C5–C8 11 2
a Deletions A–L, 10 amino acid deletions spanning the C-terminal
120 amino acids of POL2, as described previously (Ref. 9; see Table II)
and in Fig. 2, were combined with pol2-M as described under “Experi-
mental Procedures” to give pol2-M/A, etc. C1, etc. refer to the consec-
utive cysteines in ZF1 and ZF2. The cysteine-to-alanine mutations,
designated N-S, were also combined with the pol2-M mutation as de-
scribed under “Experimental Procedures” to give pol2-M/N, etc.
FIG. 2. Schematic diagram of the cysteine-rich region.
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teines of ZF1 and ZF2 of pol2-M: mutations N (C2108A,
C2111A), O (C2130A,C2133A), P (C2108A,C2111A,C2130A,
C2133A) in ZF1; and mutations Q (C2164A,C2167A), R
(C2179A,C2181A), S (C2164A,C2167A,C2179A,C2181A) in
ZF2. The mutants were first examined for their ability to sup-
port growth by the plasmid shuffling assay (9). Table I shows
that deletions A through K each abolishes growth. Because
only deletions E and F had serious growth defects in the full-
length POL2 gene, the deletions are more deleterious in the
C-terminal peptide, as might have been expected from the
growth defect in pol2-M itself. Interestingly (because we had
previously shown that deletions within ZF1 in the intact po-
lymerase were viable), cysteine-to-alanine single amino acid
changes in ZF1 of pol2-M also abolish growth (Table I). Muta-
tions that affect the cysteines of ZF2 allow slow growth at 23 °C
but are lethal at 37 °C. Thus, not only the inter-zinc finger
region but also the zinc fingers themselves contribute to the
essential function of the C terminus. ZF1 appears to be more
critical than ZF2. These mutations confirm that the C terminus
has an essential function in DNA replication independent of
the polymerization of nucleotides.
We reconstituted the intact POL2 gene carrying the cysteine-
to-alanine mutations described above. All of the full-length
cysteine-to-alanine mutants supported growth at all tempera-
tures (Table II), although the mutations affecting ZF1 grew
more slowly at the nonpermissive temperature. (Cysteine-to-
serine mutants were also viable). A comparison of the results in
Tables I and II leads to the conclusion that the presence of the
N terminus alters the contribution of the C terminus to DNA
replication, again suggesting that the polymerase portion of the
protein is important for replication when it is present.
The Role of the Zinc Fingers in the S/M Checkpoint—The
viability of cysteine-to-alanine mutants was analyzed in the
presence of HU to check their ability to activate the cell cycle
checkpoint in response to the replication block by HU. (Because
of the low viability of the pol2-M ZF mutants in the presence of
HU, these experiments were carried out with ZF mutants in
the full-length POL2 gene). The mutants were synchronized in
the G1 phase by a-factor at 23 °C and then released from the
pheromone block in the presence of HU at 37 °C. Samples were
collected at various time intervals to determine viability. Mu-
tations in ZF1 cysteines caused loss of viability, with only 20%
remaining viable after 8 h (Fig. 3). The ZF2 mutants were
comparable with POL2, having 60% viability after 8 h. The
results shown in Table II and Fig. 3 indicate that putative ZF1
plays a role in both DNA replication and the S/M checkpoint.
ZF2 is less important for both functions but also appears to
contribute. The results are consistent with our previous study
in which deletion mutants in ZF1 showed increased sensitivity
to MMS and HU and reduced damage-induced RNR3 transcrip-
tion (9).
DNA damage inducible transcription, another branch of the
S/M checkpoint, which we have shown previously to be defec-
tive in pol2-F strains, was then measured in pol2-M and pol2-
M/Q, a viable ZF2 mutant (Fig. 4). (Because the ZF1 mutants
TABLE II
Effect of Cys-to-Ala mutations in ZF1 and ZF2 in intact POL2 on
growth
Mutant Amino acidchanged Growth Growth
23 °C 37 °C
Zinc finger 1
pol2-N C1 1 C2a 111 11
pol2-O C3 1 C4 111 11
pol2-P C1–C4 111 11
Zinc finger 2
pol2-Q C5 1 C6 111 111
pol2-R C7 1 C8 111 111
pol2-S C5–C8 111 111
a C1, etc. refer to the consecutive cysteines in ZF1 and ZF2.
FIG. 3. Checkpoint defects in mutants affecting the cysteine-
rich putative zinc finger in the C terminus of POL2. A, viability of
pol2 ZF1 mutants synchronized in G1 and released into S-phase at
37 °C. Mid-log phase cells were grown in YPD (pH 3.9) and treated with
8 mg/ml a-factor at 24 °C. After 2 h, additional a-factor at 4 mg/ml was
added, and incubation was continued for 2 h at 24 °C. After 4 h, the
a-factor was removed by washing the cells in YPD, cells were released
into S-phase in the presence of 0.2 M HU, and the culture was trans-
ferred to 37 °C. Viability was determined at various time intervals by
plating cells on YPD at 24 °C. B, viability of pol2 ZF2 mutants as
described in A.
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were nonviable, they could not be tested.) Levels of RNR3 were
significantly induced by treatment of pol2-M with MMS,
showing that the checkpoint is intact. However, when a mu-
tation was introduced into ZF2, pol2-M/Q, the level of induc-
tion was significantly reduced. Thus, ZF2 is required for
setting up a functional checkpoint, even in the absence of the
polymerase domain. The low level of damage-induced induc-
tion of RNR3 in pol2-M/Q is presumably because of cells that
were not in S phase at the time of MMS treatment, as pre-
viously observed for pol2-11 and pol2-F (9, 12). The pol2-M
strain seemed to have slightly higher constitutive levels of
RNR3 transcription in the absence of damage than strains
carrying the intact DNA polymerase. Elevated constitutive
levels of RNR3 expression have also been observed in pol1
and pol3 mutants (11, 18).
DISCUSSION
The phenotypes of temperature-sensitive mutants and chro-
matin cross-linking studies have been interpreted as showing
that pol e as well as pol d and pol a all play essential roles at all
replication forks during yeast and mammalian chromosomal
replication (8, 13, 19–21). However, the precise function of pol
e is not clear. Furthermore, in the SV40 DNA in vitro replica-
tion system reconstituted from purified proteins, pol e is dis-
pensable, suggesting that the eukaryotic replication fork may
have some plasticity. Recently, a demonstration that pol d has
a dimeric structure (22, 23), like the bacterial replicases, raised
additional questions about the role of pol e at replication forks,
because the dimeric pol d could presumably coordinate leading
and lagging strand synthesis without the aid of pol e. The
suggestion was made that pol e might perform an essential
function in the maturation of Okazaki fragments (24). The
finding by Wittenberg (1) that the polymerase domain of pol e
is dispensable, which we have now also observed, at first sight
confuses the picture of polymerases at the replication fork
further. However, based on our studies of the pol e C-terminal
fragment, we propose that the polymerase domain of pol e
normally participates in replication but that another polymer-
ase can substitute in its absence. To confirm a role of the
N-terminal polymerase domain of pol e in replication, we gen-
erated a mutant in which two conserved aspartates in the
catalytic active site were changed to alanine, pol2-X, and found
that the mutation was lethal. The apparent paradox between
the viability of the deletion of the entire domain and the non-
viability of point mutants in the catalytic residues can be
explained if we consider the structure of the polymerase do-
main. The E. coli Klenow fragment, Thermus aquaticus polym-
erase, HIV reverse transcriptase, and bacteriophage RB69
class B polymerase all have a U-shaped polymerase domain
that consists of “thumb,” “palm,” and “finger” subdomains (25).
The thumb interacts with the product DNA and template, the
palm contains the polymerase active site aspartate residues,
and the fingers interact with the template and dNTPs (25, 26).
The C terminus, although performing an essential role at the
fork, lacks the primer-template binding domain, thus leaving
the primer terminus accessible to another DNA polymerase.
The pol2-X mutant affects the palm but retains the thumb and
finger primer-template domains intact and probably can still
bind to the primer, blocking accessibility to another polymer-
ase. The behavior of this mutant is in good agreement with the
fact that base analog induced mutagenesis studies strongly
suggest that the 39–59 exonuclease domain of pol e is normally
functional at the replication fork (27). It will be interesting to
see whether the pol2-X allele, with point mutations in domain
I, is dominant or recessive to overproduction of the C terminus.
Although the participation of the polymerase domain at rep-
lication forks may remain in question, it seems compelling that
the C-terminal half of pol e is essential for yeast replication and
that it can function independently of the polymerization func-
tion. Our results make it seem likely that the domain plays a
structural role in organizing other proteins at the replication
fork. Using the two-hybrid assay, we showed that the C termi-
nus of pol e can dimerize and that the inter-zinc finger muta-
tions affecting replication and the S/M checkpoint pathway are
defective both in the dimerization and interaction with Dpb2p
(9). The same mutations inactivate the replication function of
the C-terminal fragment in the absence of the polymerase. Our
current mutagenesis further refines our understanding of the
amino acids that contribute to the essential function of the C
terminus by showing that specific cysteines in ZF1 are essen-
tial and that mutations of cysteines in ZF2 lead to a tempera-
ture-sensitive phenotype. Several mutations are more delete-
rious when introduced into cells in the C-terminal fragment
rather than in the intact polymerase. A comparison of ZF2
mutants G and H (intact polymerase) and pol2-M/Q (C-termi-
nal fragment) is of interest. Mutants G and H show no growth
defect but are extremely sensitive to MMS at the restrictive
temperature, suggesting a defect in repair or damage avoid-
ance (9). pol2-M/Q is temperature-sensitive for growth. Be-
cause this domain may affect interaction with other pol e sub-
units, the simplest interpretation of the more serious defect in
pol2-M/Q is that those subunits may also make contacts with
the polymerase domain that stabilize the overall interaction.
With respect to induction of RNR3, mutant G shows only
slightly reduced induction at 23 °C, whereas pol2-M/Q shows
more complete reduction. This finding might again suggest
that proteins that interact with the C terminus also interact
with the N terminus, when present, and that these interactions
affect the damage response. Regardless of the molecular expla-
nation, the new mutants show that the N-terminal and C-
terminal functions of pol e are not totally independent.
Full-length Pol2p, with 10 amino acid deletions in ZF1, still
dimerizes and interacts with Dpb2, suggesting that ZF1 is not
required for protein/protein interactions. DNA binding is an-
other possible role for ZF1, in keeping with the function of
many zinc finger proteins. Because the C-terminal fragment
can support replication but lacks the DNA binding residues of
the polymerase active site, the C-terminal fragment must bind
FIG. 4. RNR3 expression by pol2-M mutants in the presence of
MMS. pol2-M and viable derivatives were transformed with the RNR3-
lacZ reporter, and levels of b-galactosidase were determined after treat-
ment with MMS as described previously (9). Filled bars, no MMS;
shaded bars, plus MMS.
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to the replication fork either through an independent DNA
binding domain or through interaction with another protein
that binds there. Supporting the existence of an independent
DNA binding domain, Maki and co-workers (16), using a single-
stranded DNA trap assay, demonstrated that pol e holoenzyme
dissociates from a primer-template 75-fold faster than a pol e
preparation consisting of an N-terminal 145-kDa catalytically
competent fragment of Pol2p. This enzyme also lacks the three
non-catalytic subunits of the holoenzyme (16). It was proposed
that the C terminus of pol e and/or other subunits positively
modulate a single-stranded binding site in the N terminus or
that the C terminus of pol e (and/or other subunits that interact
there) has an additional single-stranded binding site. ZF1 may
somehow contribute to single-stranded DNA recognition, be-
cause ZF1 mutants are defective in the S/M checkpoint. We
have reconstituted the Pol2pzDpb2pzDpb3pzDpb4p complex and
the pol2-Fp (lacking the inter-zinc finger domain) Dpb2pz
Dpb3pzDpb4p complexes. The pol2-Fp complexes are defective
compared with the wild type both in the stability of the com-
plexes and in the sensing of single-stranded DNA, suggesting
that there is a single-stranded DNA binding site in the C
terminus itself.2
It has recently been proposed that the lethal event during
replicational stress is the dissociation of replication complexes,
leading to an inability to complete replication when conditions
become permissive again (28). The role of the checkpoint pro-
teins in the model is therefore to stabilize stalled replication
complexes. Because the mutant pol e complexes affect the as-
sembly and structure of the fork, they may be refractory to
stabilization by checkpoint proteins, which would account for
their checkpoint defects.
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